Product Review: Medtronic MiniMed Infusion Systems
Healthcare | May, 2021
In the past few decades, there has been rapid progress in the
number of patients using subcutaneous
insulin infusion (CSII) pump therapy due to its enhanced
ability in glycaemic control and lower risk of hypoglycemia for type-1
diabetics. Current CSII therapy requires patients to wear an infusion set
linked to a pump that mimics the way the human pancreas work by delivering
small doses of short-acting insulin and variable amounts of insulin while a
meal is eaten. An infusion set consists of a thin tube/cannula inserted into
the subcutaneous tissue at an angle (made from plastic, steel, or
Teflon) and a plastic connector mounted on an adhesive patch stuck at the
insertion site. A patient reliant on CSII pump therapy can just remove the
connector to disconnect from the insulin pump temporarily without detaching the
entire infusion set. Some infusion sets can be inserted manually while others
can be inserted through an insertion device. For the success of CSII therapy to
manage diabetes, the person needs to choose the right infusion sets according
to their unique needs and preferences.
Medtronic offers a
wide range of infusion sets with different cannula types, material, length,
colour, insertion device, length of tubing, and angle of insertion for ultimate
safety and comfort. Medtronic is the only company to provide four varied types of infusion sets with
over 20 different configurations to match the specific
needs of the individual. Medtronic’s infusion set is designed for extremely
active individuals, pregnant women, children, or anyone who is whether new to
the technology or experienced. The Medtronic device gives flexibility to the
patient to wear the infusion set at alternate sites to minimize scarring, local
tissue reactions, and infections at the insertion sites. Besides, the highly
advanced infusion sets ensure more secure
insulin delivery with
audible click, silicone
membrane for the watertight reservoir, four vents in the connector for
minimizing blockage.
MINIMED® QUICK-SET™ INFUSION SET
The MINIMED® QUICK-SET™ infusion set comes with a 90-degree soft cannula that
allows optimal insulin absorption providing consistent insertion
depth. The infusion set combines ease of use with maximum comfort
enabling virtually
painless insertion in even hard-to-reach areas. The
infusion set is highly suitable for children and adults with average to large
build and it conveniently disconnects at the infusion site. The infusion set is
one of the most popular sets, which comes in various tubing and cannula
lengths. For inserting cannula under the skin, Quick-serterTM device can
be used. The device needs to be changed every 48-72 hours for enhanced insulin
absorption, reduce insulin degradation and avoid obstruction. The infusion set
can be used if you have a moderate lifestyle, often use alternate infusion
sites, and have poor dexterity. People with low body mass index should use a 6
cm cannula and 18” or 23” tubing is ideal for those who prefer to wear an
insulin pump close to the infusion site otherwise 32” or 43” works well.
MINIMED® MIO™INFUSION SET
Minimed Mio is designed for All-in-one convenience
integrating the set and insertion device in a single unit. The easy to insert and carry device comes in a variety of colors and can be inserted with only
four steps. The infusion set has a 90-degree soft
cannula and integrated inserter for virtually
painless insertion. The infusion set comes in a variety of colors such as
transparent blue or pink. The MiniMed Mio advanced infusion set has a hidden
needle throughout insertion and allows the user to insert with one hand (left
or right). The set is ideal for people who have a moderately active lifestyle,
often change insertion sites, are often on the go, and would like an option for
colors. People with low or average BMI should wear a cannula of 6 mm length.
32” tubing would be the best fit for those who prefer wearing an insulin pump
close to the infusion site. 9 mm cannula length and 32” tubing is the best fit
for people with an average of high BMI.
MINIMED® SILHOUETTE™INFUSION SET
MiniMed Silhouette comes with a variable
insertion angle from 20o to 45o
degrees providing the patient with the flexibility
to adjust the depth of insertion. The thin profile of Silhouette makes it ideal
for children and adults with lean physiques, pregnant women, or active people.
The MiniMed® silhouette features a soft Teflon cannula and Sil-serter® for
virtually painless insertion within a click of a button. The Silhouette and
reservoir need to be changed every 72 hours. People with low or average BMI
should use a 13 mm cannula and those with high should use a 17 mm cannula. For
those wearing insulin pumps close to the infusion site, 18” or 23” tubing is
right for you, otherwise 32” and 43” tubing works well.
MINIMED® SURE-T™INFUSION SET
MiniMed Sure-T is designed for enhanced security
and continuous insulin delivery. The infusion set features an ultra-thin
kink-free needle, thinnest among the MiniMed portfolio for convenience. MiniMed
Sure T has an extra disconnecting site, other than the infusion site for improved
flexibility and prevents clogging and dislodging. The infusion set is ideal for
infants, pregnant women, people with a history of bent cannulas with other
insertion sites, and those allergic to Teflon or reaction to the infusion set
with plastic cannulas. The infusion set must be changed every 24 to 48 hours
for proper prevention and care of the infusion site. People with low or average
BMI should use 6 mm needle length and use 18” or 23” tubing if they wear a
device close to the infusion site. People with average or high BMI use 8 mm or
10 mm needle length and use 23” or 32” tubing if they wear a device close to
the infusion site.
Recently, Medtronic has launched the world’s first and only infusion set that allows patients to wear it for seven
days instead of recommended three days. The advanced infusion set technology
allows people on insulin pump therapy to change their pump and set at the same
time enabling fewer interruptions and reduced mental burden of tracking site
changes. However, the new infusion set is available in a few selected European
countries starting with Finland and Belgium but is not approved for sale in the
United States of America.
How to choose the right infusion set for you?
Teflon vs Steel Cannula
While soft cannula/Teflon cannula sets are
popular due to ease of wearability and retention up to 72 hours, their
flexibility can potentially disrupt insulin flow and lead to dangerously high
blood glucose levels. Whereas steel cannulas provide better retention but for
only 48 hours. The metal one is durable and useful for people who are allergic
to Teflon. However, steel cannula can seem uncomfortable and require more
frequent site changes.
Method of Insertion
During manual insertion, the person pushes
the needle into the skin as if giving oneself an injection. The manual method
allows patients to prepare psychologically for the task and achieve a less
forceful insertion. People who are lean or like to control the speed of insertion
opt for the manual method. On the contrary, insertion devices are helpful for
people that have compromised motor skills, or needle phobia. Also, the
insertion device facilitates faster pump insertion even in areas hard-to-reach
infusion sites. However, a major limitation of the insertion device is that it
needs to be administered correctly as the user must be known how to control the
depth or exact angle of insertion while pushing the needle into the tissue.
Angle of Insertion
A 90o angled set means the needle is inserted
straight into the skin, which allows for use of a shorter needle. However,
shorter needle tends to kink and become more dislodged easily. Whereas angled
infusion sets are adapted by physically active or lean people due to less risk
of kinking or dislodging but can be less appealing to people with needle
phobia.
Tubing
The preference for tube length can depend on
person to person depending on where you plan to insert your infusion set and
where you want to wear the pump.
Site selection
Most people prefer the abdominal area for
consistent insulin absorption and the area is preferable even during pregnancy.
However, other alternate insertion sites can be buttocks, thighs, hips, or
arms. The arms and thighs have slower absorption rates, and the back of the
arms have dexterity issues. So, people prefer hips and buttocks for alternate
insertion sites due to comfort and moderate insulin absorption.
Adhesive Patch
People who engage more in physical activities
should change their adhesive patches frequently to keep the set in place as
they tend to perspire more. Some types of adhesive patches adhere better in wet
conditions or are comfortable with people with sensitive skin. So, choose the
adhesive tape that tends to suit your needs better and does not cause skin
irritation.
Conclusion
Infusion set failure is a major limitation
associate with insulin pumps, which can lead to diabetic ketoacidosis or
prolonged hyperglycemia in type-1 diabetes. Despite major innovations, the
infusion system failure rate is high therefore, key manufacturers of infusion
systems need to develop more effective and less-risky infusion systems.
However, the demand for infusion systems is set to grow in the coming years due
to the rising prevalence of diabetes and the rapid adoption of portable
healthcare devices.
According to TechSci research report on “Global
Self-monitoring
Blood Glucose Market By Type (Type 1, Type 2,
Hyperglycemia ,Hypoglycemia), By Frequency (One, Four, Others), By Product
(Glucometer, Software, Test Strips, Lancet), By End-User (Hospital, Personal
Care), By Region, Forecast & Opportunities, 2025”, the glucose self-monitoring blood glucose
market is anticipated to grow at a significant rate owing to factors such as
rising incidences of diabetic patients and faster diagnosis and treatment of
diabetes. Growing geriatric population and major technological innovations are
also anticipated to fuel the growth of self-monitoring blood glucose
market.
According to another TechSci
research report on “Global
Blood
Glucose Monitoring Devices Market By Product
Type (Self-Monitoring Glucose Devices and Continuous Glucose Monitoring
Devices), Self-Monitoring Glucose Devices (Glucometers, Test Strips, Lancets),
Continuous Glucose Monitoring Devices (Sensors, Transmitters & receivers,
Integrated Insulin Pumps), By Application (Type 1 Diabetes, Type 2 Diabetes,
Gestational Diabetes), By End User (Home Care Settings, Hospital, Others),
Forecast & Opportunities, 2026”, the global blood glucose devices market was
valued at USD15.93 billion in 2020 registering a CAGR of 6.58% during the
forecast period. The growth can be attributed to the rising incidence of
diabetes, new technological advancements, and product launches.